← 產業報告目錄
Oral Insulin Therapies Market Size, Share & Trends Analysis Report By Drug Class (Intermediate-Acting, Fast-Acting, and Long-Acting), By Application (Type 1 and Type 2 Diabetes), By Gender, Region And Segment Forecasts, 2025-2034.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-06頁數 180報告編號 INSIGHTACE-1c4253c75f
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Oral Insulin Therapies Market is forecasted to develop at a compound annual growth rate of 35.5% throughout the 2025–2034 forecast period.
The Oral Insulin Therapies sector involves dynamics.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oral Insulin Therapies Market Snapshot
Chapter 4. Global Oral Insulin Therapies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Drug Classs Estimates & Trend Analysis
5.1. By Drug Classs & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Drug Classs:
5.2.1. Fast-acting
5.2.2. Intermediate-acting
5.2.3. Long-acting
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Type 1 diabetes
6.2.2. Type 2 diabetes
Chapter 7. Market Segmentation 3: By Gender Estimates & Trend Analysis
7.1. By Gender & Market Share, 2022& 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Gender:
7.2.1. Female
7.2.2. Male
Chapter 8. Oral Insulin Therapies Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Drug Classs, 2021 - 2034
8.1.2. North America Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Application, 2021 - 2034
8.1.3. North America Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Gender, 2021 - 2034
8.1.4. North America Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts by country, 2021 - 2034
8.2. Europe
8.2.1. Europe Oral Insulin Therapies Market revenue (US$ Million) By Drug Classs, 2021 - 2034
8.2.2. Europe Oral Insulin Therapies Market revenue (US$ Million) By Application, 2021 - 2034
8.2.3. Europe Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Gender, 2021 - 2034
8.2.4. Europe Oral Insulin Therapies Market revenue (US$ Million) by country, 2021 - 2034
8.3. Asia Pacific
8.3.1. Asia Pacific Oral Insulin Therapies Market revenue (US$ Million) By Drug Classs, 2021 - 2034
8.3.2. Asia Pacific Oral Insulin Therapies Market revenue (US$ Million) By Application, 2021 - 2034
8.3.3. Asia Pacific Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Gender, 2021 - 2034
8.3.4. Asia Pacific Oral Insulin Therapies Market revenue (US$ Million) by country, 2021 - 2034
8.4. Latin America
8.4.1. Latin America Oral Insulin Therapies Market revenue (US$ Million) By Drug Classs, (US$ Million)
8.4.2. Latin America Oral Insulin Therapies Market revenue (US$ Million) By Application, (US$ Million)
8.4.3. Latin America Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Gender, 2021 - 2034
8.4.4. Latin America Oral Insulin Therapies Market revenue (US$ Million) by country, (US$ Million) 2021 - 2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Oral Insulin Therapies Market revenue (US$ Million) By Drug Classs, (US$ Million)
8.5.2. Middle East & Africa Oral Insulin Therapies Market revenue (US$ Million) By Application, (US$ Million)
8.5.3. Middle East & Africa Oral Insulin Therapies Market revenue (US$ Million) estimates and forecasts By Gender, 2021 - 2034
8.5.4. Middle East & Africa Oral Insulin Therapies Market revenue (US$ Million) by country, (US$ Million) 2021 - 2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbvie
9.2.2. GlySens Incorp
9.2.3. Echo Therapeutics
9.2.4. Medtronic
9.2.5. Sanofi
9.2.6. Novo Nordisk
9.2.7. Hoffmann-La Roche
9.2.8. MannKind Corp
9.2.9. Dexcom
9.2.10. Other Key Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們